ADVANCED VIRAL RESEARCH CORP 3
3 · ADVANCED VIRAL RESEARCH CORP · Filed Dec 4, 2007
Insider Transaction Report
Form 3
Hughes Dallas E
VP, Research
Holdings
- 6,355,932
Common Stock, par value $0.00001
Footnotes (1)
- [F1]Shares issued by the Issuer, Advanced Viral Research Corp., in exchange for certain assets owned by Reporting Person and Vincent Gullo pursuant to the terms of an asset purchase agreement among the Issuer, Triad Biotherapeutics, Inc., Vincent Gullo and Reporting Person, which closed on December 3, 2007.